Published in Ann Intern Med on August 05, 2008
Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One (2013) 1.07
Streamlining HIV testing for HIV preexposure prophylaxis. J Clin Microbiol (2014) 0.80
Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med (2008) 2.74
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med (2004) 6.87
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. JAMA (2006) 3.23
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis (2010) 2.98
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol (2004) 2.91
Comparison of group testing algorithms for case identification in the presence of test error. Biometrics (2007) 2.86
Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44
Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS (2010) 2.43
Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One (2008) 2.32
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis (2011) 2.26
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis (2013) 2.23
Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J Clin Microbiol (2008) 2.10
Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings. Arch Intern Med (2003) 1.96
Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis (2005) 1.95
The unexpected movement of the HIV epidemic in the Southeastern United States: transmission among college students. J Acquir Immune Defic Syndr (2005) 1.93
Diagnosis and management of acute HIV infection. Infect Dis Clin North Am (2007) 1.91
Differential persistence of transmitted HIV-1 drug resistance mutation classes. J Infect Dis (2011) 1.90
Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS (2007) 1.89
PCR-based pooling of dried blood spots for detection of malaria parasites: optimization and application to a cohort of Ugandan children. J Clin Microbiol (2010) 1.77
Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acquir Immune Defic Syndr (2007) 1.71
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS (2014) 1.67
Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men. PLoS One (2012) 1.64
HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells. J Immunol (2002) 1.55
Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS (2005) 1.51
Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care (2009) 1.45
Frequent detection of acute HIV infection in pregnant women. AIDS (2007) 1.43
Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009. PLoS One (2010) 1.39
Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS (2010) 1.32
Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr (2006) 1.32
Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health (2009) 1.29
"Taking a half day at a time:" patient perspectives and the HIV engagement in care continuum. AIDS Patient Care STDS (2013) 1.27
Personal health records in a public hospital: experience at the HIV/AIDS clinic at San Francisco General Hospital. J Am Med Inform Assoc (2010) 1.23
How can we better identify early HIV infections? Curr Opin HIV AIDS (2015) 1.18
A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health (2006) 1.16
Targeted testing for acute HIV infection in North Carolina. AIDS (2009) 1.14
Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency department. AIDS Patient Care STDS (2011) 1.14
HIV-1 Vif adaptation to human APOBEC3H haplotypes. Cell Host Microbe (2013) 1.07
The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting. Clin Infect Dis (2012) 1.06
Leveraging a rapid, round-the-clock HIV testing system to screen for acute HIV infection in a large urban public medical center. J Acquir Immune Defic Syndr (2013) 1.05
Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis (2012) 1.05
Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. AIDS (2003) 1.05
HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology (2013) 1.04
Clinical presentation and diagnosis of primary HIV-1 infection. Curr Opin HIV AIDS (2008) 1.04
Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retroviruses (2014) 0.96
Performance of risk-based criteria for targeting acute HIV screening in San Francisco. PLoS One (2011) 0.96
Sexual partnership patterns in malawi: implications for HIV/STI transmission. Sex Transm Dis (2011) 0.96
Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease. AIDS (2014) 0.95
Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department. Acad Emerg Med (2011) 0.93
Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men. PLoS One (2013) 0.93
Sexually transmitted infections among patients with acute HIV in North Carolina. Sex Transm Dis (2009) 0.92
Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. J Virol Methods (2011) 0.88
Methamphetamine use, transmission risk behavior and internet use among HIV-infected patients in medical care, San Francisco, 2008. AIDS Behav (2012) 0.86
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology (2014) 0.86
Mortality among antiretroviral-eligible patients in an urban public clinic. J Acquir Immune Defic Syndr (2011) 0.85
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J Infect Dis (2010) 0.85
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS (2007) 0.84
HIV infection: point-of-care testing. Ann Pharmacother (2004) 0.84
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. PLoS One (2012) 0.84
Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS (2016) 0.83
Identifying the early post-HIV antibody seroconversion period. J Infect Dis (2011) 0.82
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity. J Acquir Immune Defic Syndr (2004) 0.82
Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS (2015) 0.81
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation. Clin Infect Dis (2011) 0.81
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence. J Acquir Immune Defic Syndr (2016) 0.79
Diagnosing primary HIV infection. Ann Intern Med (2002) 0.79
Adjusting for sampling variability in sparse data: geostatistical approaches to disease mapping. Int J Health Geogr (2011) 0.79
Viral hepatitis in Hawai'i--differing perspectives. Hawaii Med J (2010) 0.78
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques. J Virol (2013) 0.78
Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection. PLoS One (2013) 0.77
The essentials of HIV: a review for nurses. J Infus Nurs (2008) 0.77
Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco. J Acquir Immune Defic Syndr (2016) 0.77
Patient perspectives on the experience of being newly diagnosed with HIV in the emergency department/urgent care clinic of a public hospital. PLoS One (2013) 0.75
Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. J Acquir Immune Defic Syndr (2011) 0.75
The lorenz curve: a novel method for understanding viral load distribution at the population level. AIDS (2016) 0.75
Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms. J Acquir Immune Defic Syndr (2017) 0.75
Limitations of using the Lorenz curve framework to understand the distribution of population viral load: authors' reply. AIDS (2017) 0.75
The safety and tolerability of Z-100 in patients infected with HIV-1. Antivir Ther (2006) 0.75